People with life-threatening illnesses may eventually see improved access to experimental drugs at an earlier stage of the federal approval process, thanks to a bill that passed the House today.
By a vote of 250-169, the House passed federal “Right to Try” legislation, pushed by the Arizona-based libertarian Goldwater Foundation. This bill allows patients with what the government classifies as a “life-threatening” illness or condition to get access to drugs that have completed the first stage of clinical trial but are not yet fully approved by the Food and Drug Administration.
Most states have such laws on the books, but the federal government itself has lagged behind them in giving citizens permission to try experimental medication sooner if they’re dying.
Read the rest at Reason.com.
Another Summit, Same Limits: What to Expect from Trump and Xi in Washington
When President Donald Trump and Chinese President Xi Jinping met in Beijing this past May, the outcome was largely as anticipated: ceremonial pomp, a handful of commercial commitments, rhetorical emphasis on “stability,” and little progress on the structural frictions...
